Sonic Healthcare Limited (AU:SHL)
ASX:SHL
Want to see AU:SHL full AI Analyst Report?
SHL Stock Chart & Stats
AU$20.56
-AU$0.19(-0.67%)
At close: 4:00 PM EST
AU$20.56
-AU$0.19(-0.67%)
Day’s Range― - ―
52-Week RangeAU$18.35 - AU$29.24
Previous CloseN/A
Volume607.50K
Average Volume (3M)1.62M
Market Cap
AU$9.26B
Enterprise ValueAU$16.38B
Total Cash (Recent Filing)AU$557.12M
Total Debt (Recent Filing)AU$7.34B
Price to Earnings (P/E)10.6
Beta0.73
Next Earnings
Aug 20, 2026EPS Estimate
0.66Next Dividend Ex-DateN/A
Dividend Yield4.69%
Share Statistics
EPS (TTM)1.11
Shares Outstanding494,237,950
10 Day Avg. Volume1,694,025
30 Day Avg. Volume1,619,425
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.55
Price to Sales (P/S)1.34
P/FCF Ratio13.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$23.56Price Target Upside14.60% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1.22
Revenue Forecast (FY)AU$10.95B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationSonic's strong free cash flow growth and high cash conversion provide durable funding for maintenance capex, acquisitions, dividends and buybacks. Reliable cash generation improves financial flexibility to absorb working-capital shocks and support disciplined capital allocation over the next 2–6 months.
Diversified Organic Revenue GrowthConsistent organic growth across geographies and service lines reduces concentration risk and supports resilient revenues. Multiple markets and segments contributing to growth (pathology, radiology, clinical services) create a more stable top-line profile through funding cycles and policy shifts.
Margin Expansion, Integration And Digital AdoptionEvidence of operating leverage from margin improvement, ongoing acquisition integration and automation indicates sustainable cost efficiencies. Digital pathology adoption and centralized platforms can lower unit costs and support scalable margins as volumes and synergies are realized over the medium term.
Bears Say
U.S. Margin Pressure And RestructuringWeak U.S. organic growth and active restructuring create a structural earnings drag; rationalising low-margin anatomical pathology lowers costs but may take time to restore profitability. Persistently lower U.S. margins could weigh on group returns and cash generation for several quarters.
Working-capital / Collections DisruptionBilling and collections disruption has inflated receivables and delayed expected collection gains, reducing near-term cash flow and increasing short-term financing needs. Deferred collection benefits and delayed earnings recognition materially affect cash conversion and leverage metrics over the next year.
Higher Net Debt From Acquisitions & PropertyAcquisition and property spending has increased net debt and interest exposure; management flags higher interest expense and tighter below‑EBITDA guidance. Elevated leverage reduces balance-sheet optionality and increases sensitivity to FX, interest-rate moves and operational setbacks over the medium term.
Sonic Healthcare Limited News
SHL FAQ
What was Sonic Healthcare Limited’s price range in the past 12 months?
Sonic Healthcare Limited lowest share price was AU$18.35 and its highest was AU$29.24 in the past 12 months.
What is Sonic Healthcare Limited’s market cap?
Sonic Healthcare Limited’s market cap is AU$9.26B.
When is Sonic Healthcare Limited’s upcoming earnings report date?
Sonic Healthcare Limited’s upcoming earnings report date is Aug 20, 2026 which is in 92 days.
How were Sonic Healthcare Limited’s earnings last quarter?
Sonic Healthcare Limited released its earnings results on Feb 18, 2026. The company reported AU$0.5 earnings per share for the quarter, missing the consensus estimate of AU$0.527 by -AU$0.027.
Is Sonic Healthcare Limited overvalued?
According to Wall Street analysts Sonic Healthcare Limited’s price is currently Undervalued.
Does Sonic Healthcare Limited pay dividends?
Sonic Healthcare Limited pays a Semiannually dividend of AU$0.63 which represents an annual dividend yield of 4.69%. See more information on Sonic Healthcare Limited dividends here
What is Sonic Healthcare Limited’s EPS estimate?
Sonic Healthcare Limited’s EPS estimate is 0.66.
How many shares outstanding does Sonic Healthcare Limited have?
Sonic Healthcare Limited has 494,237,950 shares outstanding.
What happened to Sonic Healthcare Limited’s price movement after its last earnings report?
Sonic Healthcare Limited reported an EPS of AU$0.5 in its last earnings report, missing expectations of AU$0.527. Following the earnings report the stock price went up 9.887%.
Which hedge fund is a major shareholder of Sonic Healthcare Limited?
Currently, no hedge funds are holding shares in AU:SHL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sonic Healthcare Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$23.56 (14.60% Upside)
AU$23.56 (14.60% Upside)
Blogger Sentiment
Bullish
AU:SHL Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.99%
12-Months-Change
Fundamentals
Return on Equity
6.39%
Trailing 12-Months
Asset Growth
10.74%
Trailing 12-Months
Company Description
Sonic Healthcare Limited
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
SHL Stock 12 Month Forecast
Average Price Target
AU$23.56
▲(14.60% Upside)
Technical Analysis
Healius Limited
―
Genetic Signatures Ltd.
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Monash IVF Group Ltd
―
Options Prices
Currently, No data available
---